Radboud University Medical Center: Head and Neck Neoplasms trials

The registry lists 13 Head and Neck Neoplasms studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 3Phase 3 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Individualized Follow-Up for Head and Neck CancerRecruitingNCT05386225
• Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.RecruitingNCT05333523Phase 3
• Nurse-led Follow-up Care for Head and Neck Cancer PatientsCompletedNCT01167179Not applicableResults posted
• Long Term Complications in Head and Neck Cancer PatientsStatus unknownNCT04257968Not applicable
• PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCCCompletedNCT03829007Phase 1/2
• Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation ToxicityCompletedNCT02442375Phase 3
• Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration PneumoniaStatus unknownNCT01598402Phase 2/3
• Normalcy of Food Intake in Head and Neck Cancer PatientsCompletedNCT01110980Not applicable
• Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.Status unknownNCT00782691
• TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck CancerStatus unknownNCT00774319Phase 2
• The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer PatientsCompletedNCT00184860Not applicable
• Value of FLT-PET Before and During Radiotherapy in Head and Neck TumorsCompletedNCT00163176
• Validation of 18F-MISO-PET and 18F-FLT-PETTerminatedNCT00159978